Stock ELAB ELEVAI LABS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Elevai Labs Inc.

Equities

ELAB

US28622K1043

Biotechnology & Medical Research

Delayed Nasdaq
Other stock markets
 12:02:34 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.6799 USD +4.58% Intraday chart for Elevai Labs Inc. +4.60% -62.81%
May. 02 Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity CI
May. 01 Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries CI

Business Summary

Elevai Labs, Inc. is a physician-dispensed skincare company. The Company conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. It produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare product lines. It has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.

Number of employees: 18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,329,615 3,088,647 ( 17.82 %) 0 17.82 %

Shareholders

NameEquities%Valuation
Jordan Plews
16.45 %
2,851,454 16.45 % 2 M $
Hong Yu Wang
9.858 %
1,708,406 9.858 % 1 M $
Hatem Abou-Sayed
7.917 %
1,371,905 7.917 % 924 664 $
BWL Investments Ltd.
6.578 %
1,139,965 6.578 % 768 336 $
Graydon Bensler
4.856 %
841,454 4.856 % 567 140 $
Lichti Braeden
4.778 %
828,000 4.778 % 558 072 $
Diversify Advisory Services LLC
0.3029 %
52,500 0.3029 % 35 385 $
Jeffrey Parry
0.2404 %
41,667 0.2404 % 28 084 $
Crystal Muilenburg
0.1154 %
20,000 0.1154 % 13 480 $
Brenda Buechler
0.0215 %
3,727 0.0215 % 2 512 $

Company contact information

Elevai Labs, Inc.

120 Newport Center Drive Suite 250

92660, Newport Beach

+866-794-4940

http://www.elevailabs.com
address Elevai Labs Inc.(ELAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ELEVAI LABS INC. Stock Elevai Labs Inc.
-62.81% 11.27M
MODERNA, INC. Stock Moderna, Inc.
+34.21% 50.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.85% 42.82B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.03B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.95% 26.11B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.61% 19.13B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+9.43% 13.05B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.31% 12.16B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.00% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ELAB Stock
  4. Company Elevai Labs Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW